Skip to content

8box Solutions Inc.

8box Sticky Header

RMC No. 4-2023

  • by

REVENUE MEMORANDUM CIRCULAR NO. 4-2023 issued on January 10, 2023 clarifies the base amount for the imposition of the twenty percent (20%) penalty relative to the early withdrawal of Personal Equity and Retirement Account (PERA)

RMC No. 3-2023

  • by

REVENUE MEMORANDUM CIRCULAR NO. 3-2023 issued on January 10, 2023 prescribes the policies and guidelines on the Online Registration of Books of Accounts.              Section 2 of Revenue Memorandum Circular

RMC No. 2-2023

  • by

REVENUE MEMORANDUM CIRCULAR NO. 2-2023 issued on January 6, 2023 publishes the updated List of Freedom of Information (FOI) Receiving Offices and their respective FOI Receiving Officers.

RMC No. 1-2023

  • by

REVENUE MEMORANDUM CIRCULAR NO. 1-2023 issued on January 3, 2023 announces the availability of the Interactive BIR Citizen’s Charter in the BIR Website (www.bir.gov.ph), which can be accessed under the Quick Links and BIR Transparency

RMC No. 160-2022

  • by

REVENUE MEMORANDUM CIRCULAR NO. 160-2022 issued on December 27, 2022 announces the availability of the revised Alphalist Format in the BIR Form No. 1604-C (Annual Information Return of Income Taxes Withheld on Compensation) January 2018

RMC No. 159-2022

  • by

Circularizes the Updated List of Accredited Microfinance Non-Government Organizations (NGOs) as of December 2022 REVENUE MEMORANDUM CIRCULAR NO. 159-2022 issued on December 27, 2022 circularizes the Updated List of Microfinance Non-Government Organizations (NGOs) accredited by

RMC No. 158-2022

  • by

Clarifies the effect of non-submission of a cooperative of the Taxpayer Identification Number (TIN) of its members within six (6) months from issuance of its Certificate of Tax Exemption (CTE) pursuant to Item A3 of

RMC No. 157-2022

  • by

REVENUE MEMORANDUM CIRCULARS NO. 157-2022 issued on December 27, 2022 publishes the November 28, 2022 letter from Food and Drug Administration (FDA) Director General Samuel A. Zacate endorsing updates to the “List of VAT-Exempt Medicines”

RMC No. 156-2022

  • by

REVENUE MEMORANDUM CIRCULAR NO. 156-2022 issued on December 27, 2022 publishes the November 23, 2022 letter from Food and Drug Administration (FDA) Director General Samuel A. Zacate endorsing updates to the “List of VAT-Exempt Medicines”

RMC No. 155-2022

  • by

REVENUE MEMORANDUM CIRCULAR NO. 155-2022 issued on December 27, 2022 further extends the acceptance of manually-issued Certificate of Entitlement to Tax Incentives (CETI) as an attachment to Annual Income Tax Return (AITR) to be filed